Literature DB >> 17389470

Proteomic analysis of exfoliation deposits.

Boris Ovodenko1, Agueda Rostagno, Thomas A Neubert, Vivekananda Shetty, Stefani Thomas, Austin Yang, Jeffrey Liebmann, Jorge Ghiso, Robert Ritch.   

Abstract

PURPOSE: To increase knowledge of the biochemical composition of lenticular exfoliation material (XFM) by using proteomic approaches.
METHODS: Anterior lens capsules from patients with and without exfoliation syndrome (XFS) were homogenized in formic acid and subjected to cyanogen bromide (CNBr) cleavage, and the pattern of chemically generated fragments was compared by SDS-PAGE after silver staining. Unique XFS bands not present in control cases were excised, digested with TPCK-trypsin, and the resultant peptides sequenced with quadrupole time-of-flight mass spectrometry (MS). In parallel experiments, CNBr-fragmented XFM was separately digested in solution with trypsin and elastase, and the resultant peptide mixture was analyzed by liquid chromatography coupled to tandem MS followed by identification through homology searches at nonredundant protein databases. Immunolocalization of the MS-identified components were performed in XFS versus control samples by using conventional immunohistochemical methods and light microscopy.
RESULTS: In addition to fibrillin-1, fibronectin, vitronectin, laminin, and amyloid P-component, which are well-known extracellular matrix and basement membrane components of XFM, the proteomic approaches identified the multifunctional protein clusterin and tissue inhibitor of metalloprotease (TIMP)-3 as well as novel molecules, among them fibulin-2, desmocollin-2, the glycosaminoglycans syndecan-3, and versican, membrane metalloproteases of the ADAM family (a disintegrin and metalloprotease), and the initiation component of the classic complement activation pathway C1q. In all cases, classic immunohistochemistry confirmed their location in XFM.
CONCLUSIONS: A novel solubilization strategy combined with sensitive proteomic analysis emphasizes the complexity of the XFS deposits and opens new avenues to study the molecular mechanisms involved in the pathogenesis and progression of XFS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389470     DOI: 10.1167/iovs.06-0411

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  53 in total

1.  Lack of association between LOXL1 gene polymorphisms and primary open angle glaucoma in the Saudi Arabian population.

Authors:  Khaled K Abu-Amero; Essam A Osman; Mohammad T Azad; R Rand Allingham; Michael A Hauser; Saleh A Al-Obeidan
Journal:  Ophthalmic Genet       Date:  2011-04-21       Impact factor: 1.803

2.  Detecting protein aggregates on untreated human tissue samples by atomic force microscopy recognition imaging.

Authors:  Rhiannon Creasey; Shiwani Sharma; Jamie E Craig; Christopher T Gibson; Andreas Ebner; Peter Hinterdorfer; Nicolas H Voelcker
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

Review 3.  Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis.

Authors:  Bao J Fan; Louis R Pasquale; Jae H Kang; Hani Levkovitch-Verbin; Jonathan L Haines; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2015-08-10       Impact factor: 3.467

Review 4.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Serum C-reactive protein levels in exfoliation syndrome and exfoliative glaucoma.

Authors:  M C Mocan; O Dikmetas; M Irkec
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

6.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

Review 7.  Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.

Authors:  Audrey M Bernstein; Robert Ritch; Jose M Wolosin
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

8.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

9.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

10.  Lack of association between lysyl oxidase-like 1 polymorphisms and primary open angle glaucoma: a meta-analysis.

Authors:  Wen Sun; Yan Sheng; Yu Weng; Chun-Xiao Xu; Susan E I Williams; Yu-Tao Liu; Michael A Hauser; R Rand Allingham; Ming-Juan Jin; Guang-Di Chen
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.